JP2017505336A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505336A5
JP2017505336A5 JP2016562470A JP2016562470A JP2017505336A5 JP 2017505336 A5 JP2017505336 A5 JP 2017505336A5 JP 2016562470 A JP2016562470 A JP 2016562470A JP 2016562470 A JP2016562470 A JP 2016562470A JP 2017505336 A5 JP2017505336 A5 JP 2017505336A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound according
tracer
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562470A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505336A (ja
JP6407303B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/010129 external-priority patent/WO2015103526A1/en
Publication of JP2017505336A publication Critical patent/JP2017505336A/ja
Publication of JP2017505336A5 publication Critical patent/JP2017505336A5/ja
Application granted granted Critical
Publication of JP6407303B2 publication Critical patent/JP6407303B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562470A 2014-01-05 2015-01-05 ポリ(adp−リボース)ポリメラーゼ−1(parp−1)のための放射標識トレーサー、その方法および使用 Active JP6407303B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461923759P 2014-01-05 2014-01-05
US61/923,759 2014-01-05
PCT/US2015/010129 WO2015103526A1 (en) 2014-01-05 2015-01-05 Radiolabeled tracers for poly (adp-ribose) polymerase-1 (parp-1), methods and uses therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018173457A Division JP2019001820A (ja) 2014-01-05 2018-09-18 ポリ(adp−リボース)ポリメラーゼ−1(parp−1)のための放射標識トレーサー、その方法および使用

Publications (3)

Publication Number Publication Date
JP2017505336A JP2017505336A (ja) 2017-02-16
JP2017505336A5 true JP2017505336A5 (OSRAM) 2018-02-08
JP6407303B2 JP6407303B2 (ja) 2018-10-17

Family

ID=53494075

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016562470A Active JP6407303B2 (ja) 2014-01-05 2015-01-05 ポリ(adp−リボース)ポリメラーゼ−1(parp−1)のための放射標識トレーサー、その方法および使用
JP2018173457A Withdrawn JP2019001820A (ja) 2014-01-05 2018-09-18 ポリ(adp−リボース)ポリメラーゼ−1(parp−1)のための放射標識トレーサー、その方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018173457A Withdrawn JP2019001820A (ja) 2014-01-05 2018-09-18 ポリ(adp−リボース)ポリメラーゼ−1(parp−1)のための放射標識トレーサー、その方法および使用

Country Status (7)

Country Link
US (2) US9993570B2 (OSRAM)
EP (2) EP3424909A1 (OSRAM)
JP (2) JP6407303B2 (OSRAM)
CN (1) CN106458935B (OSRAM)
CA (1) CA2935857C (OSRAM)
ES (1) ES2700348T3 (OSRAM)
WO (1) WO2015103526A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019011496A (es) 2017-03-27 2020-01-23 Tesaro Inc Composiciones de niraparib.
CN110997068B (zh) * 2017-05-24 2022-12-06 宾夕法尼亚大学董事会 用于成像和放射疗法的经放射标记的荧光parp抑制剂
BR112020006039A2 (pt) * 2017-09-26 2020-10-06 Tesaro, Inc. formulações de niraparibe
CN117180277A (zh) * 2023-08-04 2023-12-08 中国辐射防护研究院 一种核素标记的靶向探针及其制备方法和应用
CN117586270B (zh) * 2023-11-07 2025-09-23 北京脑重大疾病研究院 放射性2,7,9a-三氮杂苯并[cd]天青-6(7H)酮衍生物及其制备方法和应用
CN120247879A (zh) * 2024-01-02 2025-07-04 南京亘泰医药技术有限公司 一种parp1和ulk1双靶点抑制剂及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20011546A3 (cs) * 1998-11-03 2001-08-15 Basf Aktiengesellschaft Derivát substituovaného 2-fenylbenzimidazolu, způsob jeho přípravy a jeho použití
PL210415B1 (pl) 1999-01-11 2012-01-31 Agouron Pharma Pochodne indolu, środek farmaceutyczny i zastosowanie pochodnych indolu
ECSP003637A (es) * 1999-08-31 2002-03-25 Agouron Pharma Inhibidores triciclicos de poli (adp-ribosa) polimerasas
HU0301154D0 (en) * 2003-04-28 2003-07-28 Hideg Kalman Dr Pharmaceutical composition
GB0428012D0 (en) * 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods
US8329686B2 (en) * 2006-08-29 2012-12-11 Washington University Isatin analogues and uses therefor
US7956064B2 (en) 2006-09-01 2011-06-07 Cylene Pharmaceuticals, Inc. Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
US8506927B2 (en) * 2011-01-05 2013-08-13 Washington University Pegylated fluorobenzamide analogues, their synthesis and use in diagnostic imaging
CN104780764A (zh) 2012-09-05 2015-07-15 拜尔农作物科学股份公司 取代的2-酰氨基苯并咪唑、2-酰氨基苯并噁唑和2-酰氨基苯并噻唑或其盐作为活性物质对抗非生物植物胁迫的用途

Similar Documents

Publication Publication Date Title
JP2012107057A5 (OSRAM)
JP2011105738A5 (OSRAM)
JP2014221779A5 (OSRAM)
JP2013014622A5 (OSRAM)
JP2014507446A5 (OSRAM)
JP2017505336A5 (OSRAM)
JP2013532130A5 (OSRAM)
JP2015522045A5 (OSRAM)
JP2016518337A5 (OSRAM)
JP2018521020A5 (OSRAM)
JP2015078230A5 (OSRAM)
JP2009149903A5 (OSRAM)
JP2013032389A5 (OSRAM)
JP2011518833A5 (OSRAM)
JP2017537066A5 (OSRAM)
CN107427516B8 (zh) 7-苄基-4-(2-甲基苄基)-2,4,6,7,8,9-六氢咪唑并[1,2-a]吡啶并[3,4-e]嘧啶-5(1h)-酮、其类似物、及其盐、以及它们用于治疗的方法
JP2012111758A5 (OSRAM)
JP2017514877A5 (OSRAM)
JP2016065085A5 (OSRAM)
WO2016086036A3 (en) Methods and compositions for 18f-radiolabeling of biologics
JP2017520613A5 (OSRAM)
WO2014152389A8 (en) Imaging agent for detection of diseased cells
JP2009535462A5 (OSRAM)
JP2015503422A5 (OSRAM)
JP2011510079A5 (OSRAM)